Avita Medical Ltd. (ASX: AVH), the regenerative medicine company, announced today that it has introduced its ReCell Spray-On-Skin to dozens of clinicians from six countries of the Arabian Peninsula: Saudi Arabia, Kuwait, Bahrain, Qatar, United Arab Emirates and Oman, collectively having a population of approximately 80 million people.
